Quotient Limited (QTNT) financial statements (2021 and earlier)
Company profile
| Business Address |
28 ESPLANADE SAINT HELIER, JE2 3QA |
| State of Incorp. | |
| Fiscal Year End | March 31 |
| SIC | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments, including: | 138 | 95 | 26 | 21 | 44 | 38 | ||
| Cash and cash equivalents | 5 | 4 | 20 | 5 | 44 | 38 | ||
| Short-term investments | 133 | 91 | 6 | 16 | ||||
| Other undisclosed cash, cash equivalents, and short-term investments | (0) | (0) | (0) | (0) | ||||
| Restricted cash and investments | 0 | 0 | 0 | 0 | ||||
| Receivables | 5 | 3 | 3 | 3 | 2 | 2 | ||
| Inventory, net of allowances, customer advances and progress billings | 20 | 16 | 16 | 14 | 13 | 5 | ||
| Inventory | 20 | 16 | 16 | 14 | 13 | 5 | ||
| Other undisclosed current assets | 4 | 3 | 7 | 3 | 2 | 6 | ||
| Total current assets: | 167 | 117 | 52 | 41 | 62 | 50 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 23 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 43 | 47 | 60 | 64 | 57 | 30 | ||
| Intangible assets, net (including goodwill) | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Intangible assets, net (excluding goodwill) | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Restricted cash and investments | 9 | 8 | ||||||
| Other noncurrent assets | 5 | 5 | 5 | 0 | ||||
| Other undisclosed noncurrent assets | 1 | 1 | 6 | 5 | ||||
| Total noncurrent assets: | 81 | 61 | 72 | 69 | 58 | 31 | ||
| TOTAL ASSETS: | 248 | 178 | 124 | 110 | 120 | 81 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 21 | 24 | 23 | 23 | 14 | 16 | ||
| Accounts payable | 6 | 7 | 7 | 12 | 8 | 8 | ||
| Accrued liabilities | 5 | 4 | 7 | 3 | 3 | 5 | ||
| Employee-related liabilities | 6 | 6 | 5 | 4 | 3 | 3 | ||
| Interest and dividends payable | 4 | 7 | 5 | 5 | 0 | 0 | ||
| Debt | 4 | 0 | 1 | 1 | 1 | 5 | ||
| Deferred rent credit | 0 | ✕ | ✕ | ✕ | ✕ | |||
| Derivative instruments and hedges, liabilities | 31 | |||||||
| Other undisclosed current liabilities | 1 | 1 | 3 | 6 | 6 | 3 | ||
| Total current liabilities: | 26 | 25 | 27 | 30 | 21 | 55 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 167 | 121 | 85 | 84 | 31 | 11 | ||
| Long-term debt, excluding current maturities | 145 | 120 | 84 | 84 | 29 | 11 | ||
| Finance lease, liability | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Capital lease obligations | ✕ | 1 | 1 | 0 | 2 | 0 | ||
| Operating lease, liability | 21 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 28 | 28 | 6 | 5 | 5 | |||
| Deferred rent credit | 1 | ✕ | ✕ | ✕ | ✕ | |||
| Liability, pension and other postretirement and postemployment benefits | 8 | 7 | 6 | 5 | 5 | |||
| Financial instruments subject to mandatory redemption, settlement terms, share value, amount | 20 | 19 | ||||||
| Other undisclosed noncurrent liabilities | 9 | 2 | 20 | 15 | 16 | 17 | ||
| Total noncurrent liabilities: | 204 | 151 | 111 | 104 | 52 | 28 | ||
| Total liabilities: | 230 | 176 | 138 | 134 | 73 | 83 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | 18 | 2 | (15) | (24) | 47 | (2) | ||
| Common stock | 460 | 369 | ||||||
| Additional paid in capital | 32 | 29 | 24 | 16 | ||||
| Accumulated other comprehensive loss | (15) | (15) | (17) | (19) | (13) | (5) | ||
| Accumulated deficit | (459) | (381) | (276) | (193) | (108) | (74) | ||
| Other undisclosed stockholders' equity attributable to parent | 254 | 173 | 168 | 78 | ||||
| Total stockholders' equity: | 18 | 2 | (15) | (24) | 47 | (2) | ||
| TOTAL LIABILITIES AND EQUITY: | 248 | 178 | 124 | 110 | 120 | 81 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 32 | 29 | 25 | 22 | 19 | 18 | |
| Revenue, net | ✕ | ✕ | 25 | 22 | 19 | 18 | |
| Cost of revenue | (17) | (17) | (10) | (11) | (10) | (10) | |
| Gross profit: | 15 | 12 | 14 | 11 | 9 | 9 | |
| Operating expenses | (94) | (91) | (84) | (85) | (58) | (38) | |
| Operating loss: | (80) | (79) | (70) | (74) | (49) | (30) | |
| Nonoperating income (expense) | (25) | (26) | (13) | (11) | 15 | (29) | |
| Other nonoperating income (expense) | 1 | (6) | 2 | (1) | 4 | (4) | |
| Interest and debt expense | (4) | (6) | (4) | (7) | (1) | (1) | |
| Loss from continuing operations before equity method investments, income taxes: | (109) | (111) | (87) | (92) | (35) | (60) | |
| Other undisclosed income from continuing operations before income taxes | 4 | 6 | 4 | 7 | 1 | 1 | |
| Loss from continuing operations before income taxes: | (105) | (105) | (83) | (85) | (34) | (59) | |
| Income tax expense (benefit) | (0) | (0) | 1 | ||||
| Net loss available to common stockholders, diluted: | (105) | (105) | (82) | (85) | (34) | (59) | |
Comprehensive Income ($ in millions)
| 12/31/2019 TTM | 3/31/2019 | 3/31/2018 | 3/31/2017 | 3/31/2016 | 3/31/2015 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (105) | (105) | (82) | (85) | (34) | (59) | |
| Other comprehensive income (loss) | (0) | 2 | 3 | (7) | (8) | (5) | |
| Other undisclosed comprehensive income | 2 | ||||||
| Comprehensive loss: | (103) | (104) | (80) | (92) | (41) | (64) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (1) | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (104) | (104) | (80) | (92) | (41) | (64) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.